Anti-CanAg Antibody (Cantuzumab mertansine)
Catalog No.
F1088
Anti-CanAg Antibody (Cantuzumab mertansine)
Featured Products
Cantuzumab mertansine (SB-408075; huC242-DM1) is an ADC that is an immunoconjugate of a potent maytansine derivative and a humanized monoclonal antibody (huC242) directed against CanAg. Cantuzumab mertansine is cytotoxic to colon cancer cells and has broad antitumor activity against a range of CanAg-positive human tumor xenografts.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
400010-39-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SB408075, SB-408075, huC242-DMI
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
DM1
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CanAg
Please avoid freeze-thaw cycles.